BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30
Basel Medical Group Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 18, 2025
$4.05+0.10 (+2.53%)
Close on Oct 19, 2026
Share price
−$14.19 (−77.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Basel Medical Group Ltd grew revenue 12.6% to 11.32M SGD over fiscal 2025. Free cash flow was -4.60M SGD, down 283.9% from a year earlier.
Revenue
11.32M SGD
+12.6% vs. a year earlier
Free cash flow
-4.60M SGD
-283.9% vs. a year earlier
EPS, diluted
-0.57 SGD
-538.5% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- 11.32M SGD
- Net income
- -10.64M SGD
- EPS, diluted
- -0.57 SGD
- Free cash flow
- -4.60M SGD
Valuation needs the share price. It fills in once daily prices are connected and converted from SGD.
Three years at a glance
Fiscal years 2023 to 2025, SGD
Revenue
11.32M SGD+12.6% YoY
Net income
-10.64M SGD-613.1% YoY
EPS, diluted
-0.57 SGD-538.5% YoY
Free cash flow
-4.60M SGD-283.9% YoY
Reported period